What the first use of YorLabs’ ICE device tells us about cardiology imaging disruption
Find out how YorLabs’ FDA-cleared ICE platform could transform electrophysiology access and imaging economics in 2026.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Why 10x Genomics is betting on peripheral blood to decode complex immune disorders
Find out how 10x Genomics and Brigham & Women's Hospital are using single-cell profiling to redefine autoimmune diagnostics. Can it change patient care?
Medical Devices & Diagnostics
Why Theradaptive’s OsteoAdapt could disrupt the $2bn spinal biologics market in 2026
ATEC secures U.S. rights to Theradaptive’s OsteoAdapt. Find out what this deal changes for spinal biologics in 2026 and beyond.
Medical Devices & Diagnostics
Can Datasea’s acoustic BCI tech unlock real-world stroke rehab and assistive device control?
Datasea unveils two acoustic-powered BCI innovations targeting rehab robotics and assistive communication. Find out what this means for the future of healthcare AI.
Medical Devices & Diagnostics
Medtronic’s MiniMed Go cleared by FDA: Can smart MDI finally close the algorithm gap in diabetes care?
Medtronic’s MiniMed Go earns FDA clearance. Learn how it could reshape insulin injection therapy by combining smart pens, CGM insights, and dose algorithms.
Medical Devices & Diagnostics
Why 10x Genomics is betting on CLIA lab certification to advance spatial diagnostics in oncology
Find out how 10x Genomics and Dana-Farber aim to transform cancer diagnostics using spatial biology and single cell profiling for real-world clinical decisions.
Pharma & Biotech
Pierre Fabre and Iktos partner on AI-designed small-molecule cancer therapies
Pierre Fabre joins forces with Iktos to discover AI-designed oncology drugs. Find out what this means for cancer R&D, regulatory strategy, and pipeline speed.
Medical Devices & Diagnostics
KAON Automation acquisition expands Automated Industrial Robotics Inc.’s aseptic filling and pharmaceutical manufacturing automation capabilities
Find out how Automated Industrial Robotics Inc.’s KAON Automation acquisition strengthens aseptic filling and pharmaceutical manufacturing automation.
Pharma & Biotech
Treatment beyond progression? Zenocutuzumab data could shift standards in NRG1+ pancreatic cancer
Find out how zenocutuzumab could change treatment strategies in NRG1+ pancreatic cancer after progression. Explore new ASCO GI 2026 data today.
Pharma & Biotech
M&G backs bit.bio with $50m Series C to accelerate NAMs and AI-ready cell models
bit.bio raised $50M to expand its human cell programming platform for toxicology and AI model training. Find out why investors are backing NAMs now.